...) with clinical signs of respiratory distress syndrome and stabilized on CPAP. LUS and SatO 2 /FiO 2 were collected soon after stabilization. Their prognostic accuracy was evaluated on the subsequent surfactant administration by a rigorously masked physician. Results: One hundred seventy-five infants were...

...) during less invasive surfactant administration (LISA). Methods: This was a prospective non-randomized multicenter observational study performed in level IV NICUs. Inborn VPI with a gestational age between 22 0/7 and 31 6/7 weeks, signs of respiratory distress syndrome, and the need for surfactant...

... scores for respiratory distress syndrome (RDS; effect size 0.39 [95% confidence interval [CI]: 0.18–0.59]) and brain injury (0.36 [0.15–0.57]) than group 2, which remained significant after adjusting for gestational age, birth weight, dopamine usage, and the postnatal age at TSH screening (RDS: mean...

...David G. Sweet; Virgilio P. Carnielli; Gorm Greisen; Mikko Hallman; Katrin Klebermass-Schrehof; Eren Ozek; Arjan te Pas; Richard Plavka; Charles C. Roehr; Ola D. Saugstad; Umberto Simeoni; Christian P. Speer; Maximo Vento; Gerry H.A. Visser; Henry L. Halliday Respiratory distress syndrome (RDS...

..., a considerable proportion requires a second dose of surfactant because of ongoing respiratory distress syndrome, raising a clinical dilemma between intubation or performing a repeated LISA (re-LISA) procedure. We aim to assess efficacy of re-LISA in avoiding subsequent nasal continuous positive airway pressure...

... delivery to newborns with respiratory distress syndrome. The aim of this study was to evaluate the feasibility, safety, tolerability of a new technique of surfactant administration in newborns without anesthesia or laryngoscopy: Fiberscope Assisted Surfactant Therapy (FAST). Methods: This monocentric...

... or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Neonatal intensive care unit Lung ultrasound Point-of-care ultrasound Respiratory distress syndrome Umbilical venous catheter COVID-19 pandemic Lung ultrasound has good...

... from any ideas, methods, instructions or products referred to in the content or advertisements. Surfactant administration Respiratory distress syndrome Neonate Respiratory distress syndrome (RDS) can affect infants of all gestational ages. It is most common in preterm infants, affecting...

...Christoph Härtel; Kirsten Glaser; Christian P. Speer Surfactant replacement therapy (SRT) has long become the standard of care in the treatment of neonatal respiratory distress syndrome (RDS), significantly decreasing acute pulmonary morbidity and mortality in preterm infants. For decades...

... and the treatment of respiratory distress syndrome. Today, noninvasive respiratory support has been adopted even in the tiniest babies with the highest risk of lung injury. Moreover, different modes of noninvasive respiratory support supplemented by a number of adjunctive measures and rescue strategies have entered...

... (NCPAP) will reduce the need for invasive mechanical ventilation in preterm infants (26 0/7 –33 6/7 weeks of gestational age [GA]) with respiratory distress syndrome (RDS). Methods: This multicenter randomized controlled trial was conducted in 18 tertiary neonatal intensive care units in China. A total...

...Anne Lee Solevåg; Po-Yin Cheung; Georg M. Schmölzer Background: Bi-level noninvasive ventilation (NIV) has been used in respiratory distress syndrome (RDS) as primary treatment, post-extubation, and to treat apnea. This review summarizes studies on bi-level NIV in premature infants with RDS...

... responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Continuous positive airway pressure Early neonatal period Late preterm and term infants Neonatal adaptation Respiratory distress syndrome...

... NIPPV (NS-NIPPV) is being widely used in preterm infants without conclusive evidence of its benefits and side effects. Our aim was to evaluate whether NS-NIPPV decreases extubation failure compared with NCPAP in ventilated very low birth weight infants (VLBWI) with respiratory distress syndrome (RDS...

...Merja Kallio; Anne-Sea van der Zwaag; Andreas D. Waldmann; Marika Rahtu; Martijn Miedema; Thalia Papadouri; Anton H. van Kaam; Peter C. Rimensberger; Richard Bayford; Inéz Frerichs Background: Exogenous surfactant administration is an essential part of respiratory distress syndrome treatment...

...Maximo Vento; Kajsa Bohlin; Egbert Herting; Charles Christoph Roehr; Peter A. Dargaville Exogenous surfactant replacement is the most effective evidence-based therapy for respiratory distress syndrome in preterm infants. The mode of administration has evolved in the last decade towards less...

... from any ideas, methods, instructions or products referred to in the content or advertisements. Preterm infants Respiratory distress syndrome Continuous positive airway pressure Nasal mask Bronchopulmonary dysplasia Nasal continuous positive airway pressure (NCPAP) is a simple, low...

... with respiratory distress syndrome (RDS). Therefore, we investigated factors predictive of CPAP failure in the first 72 h of life, with special attention to the prognostic role of FiO 2 . Methods: This multicenter, prospective study enrolled infants <30 weeks gestation in whom CPAP was initiated within...

...Whittney D. Barkhuff; Roger F. Soll Traditionally, surfactant has been administered to preterm infants with respiratory distress syndrome via an endotracheal tube and in conjunction with mechanical ventilation. However, negative consequences of mechanical ventilation such as pneumothorax...

...David G. Sweet; Virgilio Carnielli; Gorm Greisen; Mikko Hallman; Eren Ozek; Arjan te Pas; Richard Plavka; Charles C. Roehr; Ola D. Saugstad; Umberto Simeoni; Christian P. Speer; Maximo Vento; Gerhard H.A. Visser; Henry L. Halliday As management of respiratory distress syndrome (RDS) advances...